Rackla expands NWT drilling, awaits assay results

Executive Summary

• Rackla Metals increased its 2025 exploration drill program by 25 % to a total of 5,000 m after early core observations expanded the known mineralized zone at the BiTe showing.
• To date, >3,100 m have been drilled across seven holes (G25‑001 to 007); all intersected sheeted quartz/sulphide‑tourmaline veins with bismuth sulphide mineralization and a broad high‑grade quartz/ tourmaline zone at depth.
• Samples from holes G25‑001 – 003 are expected within the coming week, with additional assay results pending; mapping indicates a metal zonation (arsenic‑rich ridge top, bismuth‑rich lower ridges) supporting a reduced intrusion‑related gold system model.

Key Details

• Drill Program Expansion: Original plan increased by 25 % to 5,000 m total based on encouraging core and surface work.
• Current Drilling Status: Hole G25‑008 underway, target depth 500 m; previous seven holes (G25‑001 – 007) completed, totaling >3,100 m drilled over a 500 × 300 × 550 m area.
• Core Observations:
• Abundant sheeted veining in all completed holes.
• Bismuth sulphide mineralization present throughout.
• Broad zone of intense quartz‑tourmaline veining with elevated bismuth intersected at tops of G25‑004 & 005; same zone reproduced in G25‑006 & 007 (125 m west).
• Assay Pipeline: Samples from holes G25‑001 – 003 to be received within a week; results from remaining holes expected on a rolling basis.
• Surface Mapping: Recent work shows metal zonation—arsenic‑rich gossanous ridge top, bismuth‑rich lower ridges; assays pending. Interpretation aligns with reduced intrusion‑related gold system (RIRGS) model.
• Land Holdings: Company has increased its land holdings in the region following successful regional exploration results.
• Community Relations: Ongoing consultation with Sahtu Dene and Métis communities; commitment to collaborative relationships and regulatory compliance emphasized.
• Qualified Person: Scott Casselman, BSc, PGeo, VP Exploration, reviewed and approved technical information per NI 43‑101.

Notable Quotes

(No direct quotes provided in the release.)